What is Medline, Inc. 's non-u.s.?

Medline, Inc. (MDLN) reported non-u.s. of -$6M in Q4 2025.

How has Medline, Inc. 's non-u.s. changed year-over-year?

Medline, Inc. 's non-u.s. decreased by 0.0% year-over-year, from -$6M to -$6M.

What is the long-term trend for Medline, Inc. 's non-u.s.?

Over 2 years (2023 to 2025), Medline, Inc. 's non-u.s. has grown at a 2.2% compound annual growth rate (CAGR), from -$23M to -$24M.

Medline, Inc. MDLN Non-U.S.

Non-U.S. at other companies

AccentureACN

$67.79M+134%

Restaurant Brands InternationalQSR

$24M+126%

AccentureACN

$95.74M+8.2%

ProgressivePGR

-$50.5M-181%

Bank of AmericaBAC

$1B0.0%

Exxon MobilXOM

12,000,000,000%—

Other financials

Income statement

See full

Revenue$7.4B+10.7%

Gross profit$1.8B+0.9%

Operating income$422.0M-26.1%

Net income$239.0M-25.1%

EPS (diluted)$0.16—

Balance sheet

See full

Cash & equivalents$2.2B+166%

Total debt$12.6B—

Total equity$11.3B—

Total assets$39.0B—

Cash flow

See full

Operating cash flow$412.0M-39.6%

CapEx$96.0M-2.0%

Free cash flow$316.0M-45.9%

Valuation

See full

Market cap$30.39B—

Enterprise value$40.71B—

P/E36.1×—

P/S1.1×—

Profitability

See full

Gross margin27.4%+1.5pp

Operating margin8.5%+2.3pp

Net margin4.6%+2.7pp

Returns & leverage

See full

Return on equity7.7%—

Debt / equity1.1×—

Current ratio4.4×—

Where this comes from

Reported directly by Medline, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredForeignIncomeTaxExpenseBenefit.

The official record: Medline, Inc. ’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medline, Inc. 's non-u.s..

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medline, Inc. 's non-u.s.?: Medline, Inc. (MDLN) reported non-u.s. of -$6M in Q4 2025.
How has Medline, Inc. 's non-u.s. changed year-over-year?: Medline, Inc. 's non-u.s. decreased by 0.0% year-over-year, from -$6M to -$6M.
What is the long-term trend for Medline, Inc. 's non-u.s.?: Over 2 years (2023 to 2025), Medline, Inc. 's non-u.s. has grown at a 2.2% compound annual growth rate (CAGR), from -$23M to -$24M.